Among body composition measures, reductions in fat mass and lean mass due to maridebart cafraglutide treatment were 26.2% to 36.8% and 8.6% to 11.6%, respectively, among obese participants.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks. Their effect may not ...